missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ CTS™ Viral-Plex™ Complexation Buffer
Gibco CTS Viral-Plex Complexation Buffer is a chemically defined, protein-free, phenol-red-free buffer for complexing plasmid DNA with a transfection reagent for standard transfection applications.
$266.00 - $1048.00
Spécifications
| For Use With (Application) | Transient transfection for mammalian AAV production |
|---|---|
| Physical Form | Liquid |
| Sterility | Sterile-filtered |
| Manufacturing Quality | ISO 13485, MDSAP, FDA-registered, 21 CFR 820 |
| Numéro de catalogue | Numéro du manufacturier. | Quantity | Prix | Quantité | |||||
|---|---|---|---|---|---|---|---|---|---|
| Numéro de catalogue | Numéro du manufacturier. | Quantity | Prix | Quantité | |||||
|
A5145401
|
Gibco™
A5145401 |
500 mL |
chaque for $266.00
|
|
Connectez-vous ou enregistrez-vous pour vérifier votre prix et la disponibilité.
|
||||
|
A5145402
|
Gibco™
A5145402 |
1 L |
chaque for $417.00
|
|
Connectez-vous ou enregistrez-vous pour vérifier votre prix et la disponibilité.
|
||||
|
A5145403
|
Gibco™
A5145403 |
10 L |
chaque for $1,048.00
|
|
Connectez-vous ou enregistrez-vous pour vérifier votre prix et la disponibilité.
|
||||
Description
Gibco CTS Viral-Plex Complexation Buffer is a chemically defined, protein-free, phenol-red-free buffer for complexing plasmid DNA with a transfection reagent for standard transfection applications. It is a part of the CTS AAV-MAX system and is designed to be used with the CTS AAV-MAX Transfection Kit for the transient transfection of CTS Viral Production Cells 2.0.
This buffer is manufactured in conformity with cGMP for medical devices (21 CFR Part 820) and follows USP <1043> and European Pharmacopoeia (Ph. Eur.) 5.2.12 recommendations. A Drug Master File and Regulatory Support File are available upon request.
The CTS AAV-MAX Helper-Free AAV Production System is a scalable, high-titer platform for suspension AAV production with research-grade (Cat. No. A51217) and GMP versions to enable seamless transition from research to commercial manufacturing. Other components of the CTS AAV-MAX system include CTS Viral Production Cells 2.0 (A48400), CTS Viral Production Medium (A5144001), CTS AAV-MAX Transfection Kit (A5427701), and Viral Production Medium, AGT (A5147101).
Spécifications
| Transient transfection for mammalian AAV production | |
| Liquid | |
| Sterile-filtered | |
| ISO 13485, MDSAP, FDA-registered, 21 CFR 820 |